Altria has more to gain than lose in pulling e-cigarette pods and most flavors amid FDA crackdown

In appeasing the FDA, Altria has more to gain than lose. E-cigarette sales make up a fraction of Altria's revenue. So dropping some e-vapor products won't impact its earnings as much as companies such as San Francisco start-up Juul.

from Health and Science https://ift.tt/2Atzpoz